Skip to main content
An official website of the United States government
Email

Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies

Saroj Regmi, Ph.D.

Contact Saroj Regmi to learn more about this program.

Notice Number: NOT-CA-24-001

First Available Due Date: January 25, 2024

Expiration Date: January 08, 2027

 

This Notice of Special Interest (NOSI) from the National Cancer Institute (NCI) serves to encourage applications for entrepreneurial education programs that are aimed at developing the skillset of graduate students and postdoctoral researchers, as well as early-career master’s, Ph.D., M.D., M.D./Ph.D., and Dr.P.H. scientists, in fields relevant to the NCI mission. Applications that propose innovative, state-of-the-art education programs spanning from initial translational research to the commercialization of products are encouraged. The overarching objective of this NOSI is to expand the skillset of the upcoming generation of research trainees and facilitate the commercialization of cancer-relevant technologies.

 

Background

The Center for Cancer Training (CCT) and the Small Business Innovation Research (SBIR) Development Center at the National Cancer Institute (NCI) recognize the needs of the current labor market and are seeking applications for innovation-focused educational programs that prepare graduate students and PhD-trained scientists for careers in entrepreneurship. Through this NOSI, the NCI Cancer Training Branch in the Center for Cancer Training, and SBIR Development Center aim to support institutions in preparing the next generation of scientists for careers in entrepreneurship, particularly in areas related to the NCI’s mission.

 

Applicants are encouraged to consider participation from diverse backgrounds, including those from groups that are underrepresented in the biomedical and behavioral sciences, per the NIH Interest in Diversity NOSI NOT-OD-20-031. The skillset and knowledge base should focus on increasing the understanding of the cancer entrepreneurship landscape, which can include but is not limited to: regulatory and reimbursement pathway knowledge, ability to identify unmet market needs, define value propositions, and a clear understanding of cancer product development path for drugs, devices and/or digital health solutions. The goal of the NOSI is to spur new innovative education programs in entrepreneurship. As such, it is anticipated that the applications include how the proposed course differs from other entrepreneurial training courses available at their institutions, if applicable.

For questions related to the R25 funding opportunity requirements, Nastaran Zahir, PhD at nas.zahir@nih.gov.

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Notice of Special Interest (NOSI): National Cancer Institute Entrepreneurial Education Programs to Facilitate Commercialization of Cancer Relevant Technologies was originally published by the National Cancer Institute.”

Email